Featured Research

from universities, journals, and other organizations

Naturally Produced Enzyme May Be Useful In Inflammatory Arthritis

Date:
April 27, 1998
Source:
Ohio State University
Summary:
Researchers have discovered a potential method to help treat inflammatory forms of arthritis by using an enzyme naturally produced by the human body.

COLUMBUS, Ohio -- Researchers have discovered a potential method to help treat inflammatory forms of arthritis by using an enzyme naturally produced by the human body.

Researchers found that the enzyme neutral endopeptidase (NEP) could reduce some of the effects of inflammatory arthritis, according to a study in a recent issue of the journal Inflammation.

“NEP holds promise as a unique therapeutic strategy for the treatment of inflammatory arthritis,” said Patrick Ward, professor of physiology at Ohio State University and co-author of the study.

NEP works to control the levels of certain peptides, such as bradykinin, that have been linked to joint inflammation found in arthritis patients.

Peptides, short chains of amino acids, can produce inflammatory-type reactions, such as pain and increased blood flow, associated with tissue break-down. In healthy individuals, NEP is one of the enzymes which controls the effects of such peptides, Ward said.

Ward and his colleagues tested synovial fluid from the joints of three patients with rheumatoid arthritis. The researchers then added NEP to the fluid and found that NEP decreased the negative effect of the inflammatory peptide bradykinin.

While NEP could potentially be used as a drug, its high cost and the difficulty of delivery to inflamed sites would limit its use. However, Ward said that gene therapy may be a more logical solution.

“If the body is unable to manufacture enough NEP to control the inflammatory effects of these peptides, it may be possible to stimulate synovial cells to make more of their own NEP,” Ward said. He and his colleagues suggest that gene therapy may be used to insert a gene that controls NEP production.

The extra levels of the enzyme could then degrade inflammation-causing peptides and decrease damage and/or pain in joints. This concept is consistent with the broader approach of stimulating natural substances to control disease, Ward said.

“Stimulating natural substances to work at their normal sites of action has the potential to produce therapeutic actions with minimal negative side effects,” Ward said.

He added that this research was simply a feasibility study and no drug company routinely manufactures NEP yet. “If a drug company made it, the next step would be to run clinical trials that directly examine the influence of NEP in the joint. Such studies would further test the potential of NEP as a therapeutic agent for inflamed joints.”

Other researchers included Nancie Solan, Scherer Sander, Marilyn Towns and Joan Bathon, all of Johns Hopkins University School of Medicine. Grants from the National Institutes of Health and a California pharmaceutical company funded the study.


Story Source:

The above story is based on materials provided by Ohio State University. Note: Materials may be edited for content and length.


Cite This Page:

Ohio State University. "Naturally Produced Enzyme May Be Useful In Inflammatory Arthritis." ScienceDaily. ScienceDaily, 27 April 1998. <www.sciencedaily.com/releases/1998/04/980427081636.htm>.
Ohio State University. (1998, April 27). Naturally Produced Enzyme May Be Useful In Inflammatory Arthritis. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/1998/04/980427081636.htm
Ohio State University. "Naturally Produced Enzyme May Be Useful In Inflammatory Arthritis." ScienceDaily. www.sciencedaily.com/releases/1998/04/980427081636.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins